2022 Q1 Form 10-Q Financial Statement

#000165495422006656 Filed on May 13, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $8.252M $8.617M
YoY Change -4.24% 10.87%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $285.2K $260.0K
YoY Change 9.69% 13.04%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $693.3K $854.4K
YoY Change -18.86% -42.13%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $2.929M $3.702M
YoY Change -20.9% 69.84%
Income Tax $523.0K $676.5K
% Of Pretax Income 17.86% 18.27%
Net Earnings $2.406M $3.026M
YoY Change -20.5% 62.56%
Net Earnings / Revenue 29.15% 35.11%
Basic Earnings Per Share $0.44 $0.57
Diluted Earnings Per Share $446.9K $569.5K
COMMON SHARES
Basic Shares Outstanding 5.383M shares 5.322M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $84.45M $93.19M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $13.50M $12.56M
YoY Change 7.52% 16.28%
Goodwill $11.57M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.005B $937.5M
YoY Change 7.22% 24.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.898M $2.700M
YoY Change 7.32% -15.63%
Accrued Expenses $812.0K $1.000M
YoY Change -18.8% -16.67%
Deferred Revenue
YoY Change
Short-Term Debt $28.74M $32.10M
YoY Change -10.45% 40.17%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.710M $3.700M
YoY Change 0.26% -15.91%
LONG-TERM LIABILITIES
Long-Term Debt $16.69M $15.30M
YoY Change 9.1% 17.69%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $16.69M $15.30M
YoY Change 9.1% 17.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.710M $3.700M
Total Long-Term Liabilities $16.69M $15.30M
Total Liabilities $927.7M $859.4M
YoY Change 7.95% 26.18%
SHAREHOLDERS EQUITY
Retained Earnings $31.21M
YoY Change
Common Stock $13.86M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.623M
YoY Change
Treasury Stock Shares 210.1K shares 210.1K shares
Shareholders Equity $77.44M $78.09M
YoY Change
Total Liabilities & Shareholders Equity $1.005B $937.5M
YoY Change 7.22% 24.72%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $2.406M $3.026M
YoY Change -20.5% 62.56%
Depreciation, Depletion And Amortization $285.2K $260.0K
YoY Change 9.69% 13.04%
Cash From Operating Activities $2.708M $5.877M
YoY Change -53.92% 547.48%
INVESTING ACTIVITIES
Capital Expenditures -$70.69K -$2.660M
YoY Change -97.34% 2116.67%
Acquisitions
YoY Change
Other Investing Activities -$21.61M -$43.28M
YoY Change -50.06% 89.91%
Cash From Investing Activities -$21.68M -$45.94M
YoY Change -52.8% 100.44%
FINANCING ACTIVITIES
Cash Dividend Paid $900.9K
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00 $500.0K
YoY Change -100.0%
Cash From Financing Activities -$6.931M $18.20M
YoY Change -138.07% 50.72%
NET CHANGE
Cash From Operating Activities $2.708M $5.877M
Cash From Investing Activities -$21.68M -$45.94M
Cash From Financing Activities -$6.931M $18.20M
Net Change In Cash -$25.91M -$21.86M
YoY Change 18.53% 120.06%
FREE CASH FLOW
Cash From Operating Activities $2.708M $5.877M
Capital Expenditures -$70.69K -$2.660M
Free Cash Flow $2.779M $8.537M
YoY Change -67.45% 730.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5391518 shares
CY2022Q1 cmtv Time Deposits Over
TimeDepositsOver
250000 USD
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
15 shares
CY2022Q1 us-gaap Preferred Stock Liquidation Preference Value
PreferredStockLiquidationPreferenceValue
100000 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5602178 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5587939 shares
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
210101 shares
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
7487200 USD
CY2021Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
8253296 USD
CY2022Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
667226 USD
CY2021Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
265112 USD
CY2022Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
16460 USD
CY2021Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
10619 USD
CY2022Q1 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
80660 USD
CY2021Q1 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
87883 USD
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
8251546 USD
CY2021Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
8616910 USD
CY2022Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
551959 USD
CY2021Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
705244 USD
CY2022Q1 us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
21965 USD
CY2021Q1 us-gaap Interest Expense Federal Funds Purchased
InterestExpenseFederalFundsPurchased
14941 USD
CY2022Q1 us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
21040 USD
CY2021Q1 us-gaap Repurchase Agreements Interest Expense Amount
RepurchaseAgreementsInterestExpenseAmount
35442 USD
CY2022Q1 us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
98352 USD
CY2021Q1 us-gaap Interest Expense Junior Subordinated Debentures
InterestExpenseJuniorSubordinatedDebentures
98795 USD
CY2022Q1 us-gaap Interest Expense
InterestExpense
693316 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
854422 USD
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7558230 USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7762488 USD
CY2022Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
862500 USD
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
267497 USD
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
6695730 USD
CY2021Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
7494991 USD
CY2022Q1 cmtv Service Fee Income
ServiceFeeIncome
862887 USD
CY2021Q1 cmtv Service Fee Income
ServiceFeeIncome
788623 USD
CY2022Q1 us-gaap Interest And Fee Income Loans Held For Sale Mortgages
InterestAndFeeIncomeLoansHeldForSaleMortgages
203842 USD
CY2021Q1 us-gaap Interest And Fee Income Loans Held For Sale Mortgages
InterestAndFeeIncomeLoansHeldForSaleMortgages
185006 USD
CY2022Q1 us-gaap Interest And Fee Income Other Loans
InterestAndFeeIncomeOtherLoans
271260 USD
CY2021Q1 us-gaap Interest And Fee Income Other Loans
InterestAndFeeIncomeOtherLoans
183274 USD
CY2022Q1 us-gaap Other Income
OtherIncome
348440 USD
CY2021Q1 us-gaap Other Income
OtherIncome
415328 USD
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
1686429 USD
CY2021Q1 us-gaap Noninterest Income
NoninterestIncome
1572231 USD
CY2022Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
2040000 USD
CY2021Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
1975003 USD
CY2022Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
772052 USD
CY2021Q1 us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
831210 USD
CY2022Q1 us-gaap Occupancy Net
OccupancyNet
753364 USD
CY2021Q1 us-gaap Occupancy Net
OccupancyNet
744720 USD
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1888172 USD
CY2021Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1814118 USD
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
5453588 USD
CY2021Q1 us-gaap Noninterest Expense
NoninterestExpense
5365051 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2928571 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3702171 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
523029 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
676470 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2405542 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3025701 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5382678 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5322404 shares
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.23
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.22
CY2022Q1 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
-11069161 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Securities
UnrealizedGainLossOnSecurities
-1660640 USD
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-2324524 USD
CY2022Q1 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-8744637 USD
CY2021Q1 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-1311905 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6339095 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
84760268 USD
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
272683 USD
CY2022Q1 cmtv Cash Dividends Declared Common Stock
CashDividendsDeclaredCommonStock
-1236880 USD
CY2022Q1 cmtv Cash Dividends Declared Preferred Stock
CashDividendsDeclaredPreferredStock
-12188 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2405542 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-8744637 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
77444788 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
77288713 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
264779 USD
CY2021Q1 cmtv Cash Dividends Declared Common Stock
CashDividendsDeclaredCommonStock
-1169555 USD
CY2021Q1 cmtv Cash Dividends Declared Preferred Stock
CashDividendsDeclaredPreferredStock
-12188 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3025701 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-1311905 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
78085545 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2405542 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3025701 USD
CY2022Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
285202 USD
CY2021Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
259449 USD
CY2022Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
862500 USD
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
267497 USD
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
47344 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
16608 USD
CY2022Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
102945 USD
CY2021Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
114211 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
225870 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1693014 USD
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
186967 USD
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
95456 USD
CY2022Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
4425711 USD
CY2021Q1 us-gaap Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
2145611 USD
CY2022Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
4229766 USD
CY2021Q1 us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
2435200 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
408593 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
569100 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
318578 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
250630 USD
CY2022Q1 us-gaap Servicing Asset At Amortized Value Period Increase Decrease
ServicingAssetAtAmortizedValuePeriodIncreaseDecrease
-2374 USD
CY2021Q1 us-gaap Servicing Asset At Amortized Value Period Increase Decrease
ServicingAssetAtAmortizedValuePeriodIncreaseDecrease
38280 USD
CY2022Q1 cmtv Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
49669 USD
CY2021Q1 cmtv Increase Decrease In Right Of Use Assets
IncreaseDecreaseInRightOfUseAssets
49031 USD
CY2022Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-51283 USD
CY2021Q1 us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-49198 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
173852 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
148665 USD
CY2022Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
20060 USD
CY2021Q1 us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
21673 USD
CY2022Q1 cmtv Amortization Of Limited Partnership
AmortizationOfLimitedPartnership
67092 USD
CY2021Q1 cmtv Amortization Of Limited Partnership
AmortizationOfLimitedPartnership
90762 USD
CY2022Q1 us-gaap Increase Decrease In Loans Deferred Income
IncreaseDecreaseInLoansDeferredIncome
312318 USD
CY2021Q1 us-gaap Increase Decrease In Loans Deferred Income
IncreaseDecreaseInLoansDeferredIncome
-1076424 USD
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-1332 USD
CY2021Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-12953 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-567062 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-420431 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-24896 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3175 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2708284 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5877147 USD
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
4434388 USD
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
4383743 USD
CY2022Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
19103623 USD
CY2021Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
27371666 USD
CY2022Q1 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
43500 USD
CY2021Q1 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
0 USD
CY2022Q1 cmtv Decrease In Limited Partnership Contributions Payable
DecreaseInLimitedPartnershipContributionsPayable
0 USD
CY2021Q1 cmtv Decrease In Limited Partnership Contributions Payable
DecreaseInLimitedPartnershipContributionsPayable
-150000 USD
CY2022Q1 us-gaap Increase Decrease In Other Loans
IncreaseDecreaseInOtherLoans
-6998537 USD
CY2021Q1 us-gaap Increase Decrease In Other Loans
IncreaseDecreaseInOtherLoans
-20167317 USD
CY2021Q1 us-gaap Proceeds From Recoveries Of Loan Previously Charged Off
ProceedsFromRecoveriesOfLoanPreviouslyChargedOff
25314 USD
CY2021Q1 cmtv Total Dividends Paid
TotalDividendsPaid
743679 USD
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
70686 USD
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2657300 USD
CY2022Q1 us-gaap Proceeds From Recoveries Of Loan Previously Charged Off
ProceedsFromRecoveriesOfLoanPreviouslyChargedOff
11780 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21683178 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45937226 USD
CY2022Q1 us-gaap Increase Decrease In Demand Deposits
IncreaseDecreaseInDemandDeposits
-12916068 USD
CY2021Q1 us-gaap Increase Decrease In Demand Deposits
IncreaseDecreaseInDemandDeposits
7863790 USD
CY2022Q1 us-gaap Increase Decrease In Savings Deposits
IncreaseDecreaseInSavingsDeposits
10606091 USD
CY2021Q1 us-gaap Increase Decrease In Savings Deposits
IncreaseDecreaseInSavingsDeposits
19474878 USD
CY2022Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
210469 USD
CY2021Q1 us-gaap Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
-3639187 USD
CY2022Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
-3865864 USD
CY2021Q1 us-gaap Proceeds From Payments For In Securities Sold Under Agreements To Repurchase
ProceedsFromPaymentsForInSecuritiesSoldUnderAgreementsToRepurchase
-6627854 USD
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2021Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
500000 USD
CY2022Q1 cmtv Increase Decrease In Finance Lease Obligations
IncreaseDecreaseInFinanceLeaseObligations
-52807 USD
CY2021Q1 cmtv Increase Decrease In Finance Lease Obligations
IncreaseDecreaseInFinanceLeaseObligations
2388819 USD
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
12188 USD
CY2021Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
12188 USD
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
900893 USD
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
743679 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6931260 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18204579 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-25906154 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21855500 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
110358926 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
115049920 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
84452772 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93194420 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
694648 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
867375 USD
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-11069161 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
-1660640 USD
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1236880 USD
CY2021Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1169555 USD
CY2022Q1 cmtv Increase In Dividends Payable Attributable To Dividends Declared
IncreaseInDividendsPayableAttributableToDividendsDeclared
-63304 USD
CY2021Q1 cmtv Increase In Dividends Payable Attributable To Dividends Declared
IncreaseInDividendsPayableAttributableToDividendsDeclared
-161097 USD
CY2022Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
272683 USD
CY2021Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
264779 USD
CY2022Q1 cmtv Total Dividends Paid
TotalDividendsPaid
900893 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2405542 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
3025701 USD
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
12188 USD
CY2021Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
12188 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2393354 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5322404 shares
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2022Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
198301905 USD
CY2022Q1 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
96488 USD
CY2022Q1 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
12642827 USD
CY2022Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
185755566 USD
CY2021Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
183819638 USD
CY2021 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
445806 USD
CY2021 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
1922985 USD
CY2021Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
182342459 USD
CY2022Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
142772046 USD
CY2022Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
9076699 USD
CY2022Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
34447467 USD
CY2022Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
3566128 USD
CY2022Q1 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
186 integer
CY2022Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
177219513 USD
CY2022Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
12642827 USD
CY2021Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
147512619 USD
CY2021Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1629983 USD
CY2021Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
10730872 USD
CY2021Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
293002 USD
CY2021Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
144 integer
CY2021Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
158243491 USD
CY2021Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
1922985 USD
CY2022Q1 cmtv Loans Receivable Commercial Industrial
LoansReceivableCommercialIndustrial
121473157 USD
CY2021Q4 cmtv Loans Receivable Commercial Industrial
LoansReceivableCommercialIndustrial
120933470 USD
CY2022Q1 cmtv Loans Receivable Real Estate Commercial
LoansReceivableRealEstateCommercial
308311734 USD
CY2021Q4 cmtv Loans Receivable Real Estate Commercial
LoansReceivableRealEstateCommercial
300958931 USD
CY2022Q1 cmtv Loans Receivable Municipal
LoansReceivableMunicipal
48660440 USD
CY2021Q4 cmtv Loans Receivable Municipal
LoansReceivableMunicipal
47955231 USD
CY2022Q1 cmtv Residential Real Estate First St Lien
ResidentialRealEstateFirstStLien
181610294 USD
CY2021Q4 cmtv Residential Real Estate First St Lien
ResidentialRealEstateFirstStLien
181316345 USD
CY2022Q1 cmtv Residential Real Estate Jr Lien
ResidentialRealEstateJrLien
33066989 USD
CY2021Q4 cmtv Residential Real Estate Jr Lien
ResidentialRealEstateJrLien
34359864 USD
CY2022Q1 cmtv Loan And Lease Receivable Consumer
LoanAndLeaseReceivableConsumer
3170568 USD
CY2021Q4 cmtv Loan And Lease Receivable Consumer
LoanAndLeaseReceivableConsumer
4464692 USD
CY2022Q1 cmtv Loans Gross
LoansGross
696293182 USD
CY2021Q4 cmtv Loans Gross
LoansGross
689988533 USD
CY2022Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7890648 USD
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
7710256 USD
CY2022Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
8229830 USD
CY2022Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
59063 USD
CY2022Q1 cmtv Accrued Interest Receivable And Deferred Net Loan Costs
AccruedInterestReceivableAndDeferredNetLoanCosts
38479 USD
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
79978 USD
CY2021Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
8489239 USD
CY2021Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
10149243 USD
CY2021 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
7355724 USD
CY2021Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
267497 USD
CY2021Q1 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
7468288 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
119561 USD
CY2021Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
7348727 USD
CY2021Q1 cmtv Total All Evaluted For Impairment
TotalAllEvalutedForImpairment
7468288 USD
CY2021Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
6604259 USD
CY2021Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
722885380 USD
CY2021Q1 cmtv Total Loans Evaluted For Impairment
TotalLoansEvalutedForImpairment
729489639 USD
CY2022Q1 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
-274346 USD
CY2021Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
37972 USD
CY2022Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
688676880 USD
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
682240305 USD
CY2022Q1 cmtv Financing Receivable Recorded Investment30 To89 Days Past Due
FinancingReceivableRecordedInvestment30To89DaysPastDue
3088102 USD
CY2022Q1 cmtv Financing Receivable Recorded Investment90 Days Or More Past Due
FinancingReceivableRecordedInvestment90DaysOrMorePastDue
2487339 USD
CY2022Q1 cmtv Notes Receivable Gross Financial Asset Past Due
NotesReceivableGrossFinancialAssetPastDue
5575441 USD
CY2022Q1 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
690717741 USD
CY2022Q1 cmtv Loans Gross
LoansGross
696293182 USD
CY2022Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
5414963 USD
CY2022Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
654814 USD
CY2021Q4 cmtv Financing Receivable Recorded Investment30 To89 Days Past Due
FinancingReceivableRecordedInvestment30To89DaysPastDue
2135203 USD
CY2021Q4 cmtv Financing Receivable Recorded Investment90 Days Or More Past Due
FinancingReceivableRecordedInvestment90DaysOrMorePastDue
3095765 USD
CY2021Q4 cmtv Notes Receivable Gross Financial Asset Past Due
NotesReceivableGrossFinancialAssetPastDue
5230968 USD
CY2021Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
684757565 USD
CY2021Q4 cmtv Loans Gross
LoansGross
689988533 USD
CY2021Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
5940629 USD
CY2021Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
593303 USD
CY2022Q1 cmtv Residential Mortgage Loans In Process Of Foreclosure Number Of Loans
ResidentialMortgageLoansInProcessOfForeclosureNumberOfLoans
4 integer
CY2022Q1 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
153054 USD
CY2021Q4 cmtv Residential Mortgage Loans In Process Of Foreclosure Number Of Loans
ResidentialMortgageLoansInProcessOfForeclosureNumberOfLoans
5 integer
CY2021Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
195082 USD
CY2021Q4 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
7710256 USD
CY2022Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
-693888 USD
CY2022Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
11780 USD
CY2022Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
862500 USD
CY2022Q1 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
7890648 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
115614 USD
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
7775034 USD
CY2022Q1 cmtv Total All Evaluted For Impairment
TotalAllEvalutedForImpairment
7890648 USD
CY2022Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
7931944 USD
CY2022Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
688361238 USD
CY2022Q1 cmtv Total Loans Evaluted For Impairment
TotalLoansEvalutedForImpairment
696293182 USD
CY2020Q4 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
7208485 USD
CY2021 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
-227202 USD
CY2021 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
104808 USD
CY2021 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
624165 USD
CY2021Q4 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
7710256 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
79978 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
7630278 USD
CY2021 cmtv Total All Evaluted For Impairment
TotalAllEvalutedForImpairment
7710256 USD
CY2021Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
8456162 USD
CY2021Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
681532371 USD
CY2021 cmtv Total Loans Evaluted For Impairment
TotalLoansEvalutedForImpairment
689988533 USD
CY2020Q4 us-gaap Allowance For Loan And Lease Losses Real Estate
AllowanceForLoanAndLeaseLossesRealEstate
7208485 USD
CY2021Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
-33008 USD
CY2021Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
25314 USD
CY2022Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
115614 USD
CY2022Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
7970423 USD
CY2022Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
10227884 USD
CY2021Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
6910952 USD
CY2021Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
67973 USD
CY2021Q1 cmtv Accrued Interest Receivable And Deferred Net Loan Costs
AccruedInterestReceivableAndDeferredNetLoanCosts
34764 USD
CY2022Q1 cmtv Group A Acceptable Risk Loan
GroupAAcceptableRiskLoan
679778161 USD
CY2021 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
387912 USD
CY2021Q4 cmtv Accrued Interest Receivable And Deferred Net Loan Costs
AccruedInterestReceivableAndDeferredNetLoanCosts
33077 USD
CY2021Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
6639023 USD
CY2021Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
8103430 USD
CY2021Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
119561 USD
CY2022Q1 cmtv Group B Management Involved Loans
GroupBManagementInvolvedLoans
3001861 USD
CY2022Q1 cmtv Group C Unacceptable Risk Loan
GroupCUnacceptableRiskLoan
13513160 USD
CY2022Q1 cmtv Loans Gross Amount
LoansGrossAmount
696293182 USD
CY2021Q4 cmtv Group A Acceptable Risk Loan
GroupAAcceptableRiskLoan
667382286 USD
CY2021Q4 cmtv Group B Management Involved Loans
GroupBManagementInvolvedLoans
7243419 USD
CY2021Q4 cmtv Group C Unacceptable Risk Loan
GroupCUnacceptableRiskLoan
15362828 USD
CY2021Q4 cmtv Loans Gross Amount
LoansGrossAmount
689988533 USD
CY2021 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
4 integer
CY2021 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
3262160 USD
CY2021 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
3262160 USD
CY2021 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
3 integer
CY2021 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
3119811 USD
CY2021Q1 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
2 integer
CY2021Q1 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
203822 USD
CY2022Q1 cmtv Allowance Related To Tdrs
AllowanceRelatedToTdrs
115614 USD
CY2021Q4 cmtv Allowance Related To Tdrs
AllowanceRelatedToTdrs
79978 USD
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
185755566 USD
CY2021Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
182342459 USD
CY2021Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
897720 USD
CY2020Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
922146 USD
CY2022Q1 us-gaap Payments For Proceeds From Mortgage Servicing Rights
PaymentsForProceedsFromMortgageServicingRights
45304 USD
CY2021 us-gaap Payments For Proceeds From Mortgage Servicing Rights
PaymentsForProceedsFromMortgageServicingRights
147328 USD
CY2022Q1 us-gaap Amortization Of Mortgage Servicing Rights Ms Rs
AmortizationOfMortgageServicingRightsMSRs
42930 USD
CY2021 us-gaap Amortization Of Mortgage Servicing Rights Ms Rs
AmortizationOfMortgageServicingRightsMSRs
225404 USD
CY2022Q1 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
0 USD
CY2021 us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
53650 USD
CY2022Q1 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
900094 USD
CY2021Q4 us-gaap Servicing Asset At Amortized Value
ServicingAssetAtAmortizedValue
897720 USD
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.23

Files In Submission

Name View Source Status
0001654954-22-006656-index-headers.html Edgar Link pending
0001654954-22-006656-index.html Edgar Link pending
0001654954-22-006656.txt Edgar Link pending
0001654954-22-006656-xbrl.zip Edgar Link pending
cmtv-20220331.xsd Edgar Link pending
cmtv-20220331_cal.xml Edgar Link unprocessable
cmtv-20220331_def.xml Edgar Link unprocessable
cmtv-20220331_lab.xml Edgar Link unprocessable
cmtv-20220331_pre.xml Edgar Link unprocessable
cmtv_10q.htm Edgar Link pending
cmtv_10qimg2.jpg Edgar Link pending
cmtv_10q_htm.xml Edgar Link completed
cmtv_ex311.htm Edgar Link pending
cmtv_ex312.htm Edgar Link pending
cmtv_ex321.htm Edgar Link pending
cmtv_ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending